ASP Isotopes Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $23.8M | $4.1M | $433,026 | $0 | — |
| Cost of revenue | $20.4M | $2.5M | $294,056 | $0 | — |
| Gross profit | $3.4M | $1.6M | $138,970 | $0 | — |
| Research and development | $12.4M | $3.1M | $764,581 | $1.3M | — |
| Operating expenses | $63.3M | $28.0M | $16.2M | $5.1M | — |
| Operating income | -$59.9M | -$26.4M | -$16.0M | -$5.1M | — |
| Interest expense | $575,000 | $259,000 | $118,547 | $0 | — |
| Pretax income | -$159.6M | -$32.3M | -$16.3M | -$4.9M | — |
| Income tax expense | $282,000 | $111,000 | -$6,133 | $0 | — |
| Net income | -$159.8M | -$32.4M | -$16.3M | -$4.9M | — |
| Balance Sheet | |||||
| Cash and equivalents | $285.6M | $61.9M | — | — | — |
| Current assets | $399.9M | $65.7M | $10.5M | $3.3M | $3.2M |
| Total assets | $498.0M | $94.3M | $27.5M | $12.5M | $7.1M |
| Current liabilities | $32.7M | $7.1M | $5.7M | $1.9M | $303,351 |
| Total liabilities | $235.1M | $43.2M | $8.7M | $2.7M | $1.1M |
| Stockholders' equity | $204.2M | $47.9M | $16.3M | $9.8M | $6.0M |
| Cash Flow Statement | |||||
| Cash from operations | -$37.8M | -$16.7M | -$5.4M | -$2.9M | — |
| Depreciation and amortization | $1.9M | $471,000 | $37,433 | $0 | — |
| Stock-based compensation | $16.0M | $8.6M | $8.7M | $2.0M | — |
| Capital expenditure | $9.7M | $9.7M | $2.3M | $4.5M | — |
| Free cash flow | -$47.4M | -$26.4M | -$7.7M | -$7.4M | — |
| Dividends paid | $0 | $2.8M | $0 | — | — |
| Impairments | $0 | $0 | — | — | — |
Shares outstanding 125.9M · Free float 42.5%
Annual filing data through FY ended December 31, 2025; float as of July 16, 2026.